Indeed, several studies have concluded that an altered expression of ANRIL might enhance the negative evolution of coronary heart disease and that modified ANRIL transcription and splicing are correlated to the specific polymorphism of a single base [219]. Here, CDKN2B-AS1 is linked to coronary artery disorder.